KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $33,342,000 | +3512.4% | 185,421 | +1983.9% | 0.03% | +3000.0% |
| Q2 2017 | $923,000 | +54.6% | 8,898 | +17.0% | 0.00% | 0.0% |
| Q1 2017 | $597,000 | +26.5% | 7,605 | -17.9% | 0.00% | – |
| Q4 2016 | $472,000 | +31.8% | 9,262 | +44.6% | 0.00% | – |
| Q3 2016 | $358,000 | +11.9% | 6,405 | 0.0% | 0.00% | – |
| Q2 2016 | $320,000 | +2185.7% | 6,405 | +2056.6% | 0.00% | – |
| Q1 2016 | $14,000 | -22.2% | 297 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | -82.0% | 297 | -83.5% | 0.00% | – |
| Q3 2015 | $100,000 | -92.8% | 1,797 | -92.1% | 0.00% | -100.0% |
| Q2 2015 | $1,389,000 | +2.6% | 22,781 | -2.9% | 0.00% | 0.0% |
| Q1 2015 | $1,354,000 | +515.5% | 23,453 | +514.8% | 0.00% | – |
| Q4 2014 | $220,000 | +165.1% | 3,815 | +30.6% | 0.00% | – |
| Q3 2014 | $83,000 | – | 2,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |